Impact of Resistance Training Intensity on Blood Pressure
Launched by UNIVERSITÉ DE SHERBROOKE · Feb 19, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different levels of resistance training intensity affect blood pressure in women aged 50 to 70. The researchers want to learn if lifting lighter weights (50% of what a person can lift once) or heavier weights (80% of that maximum) while putting in the same level of effort can lower blood pressure after exercising. They will also explore how these exercises impact overall heart health and whether participants enjoy the workouts.
To participate, women must be between 50 and 70 years old, have a specific range of resting blood pressure, and should not have been active in structured exercise for at least three months. Participants will go through a few visits for assessments and familiarization before engaging in three experimental workout sessions, which include both the low and high resistance training and a control task that doesn’t involve physical effort. This study is not yet recruiting participants but aims to provide valuable insights into how exercise can help manage blood pressure in older women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • aged 50 to 70 years;
- • absence of menstruation for 12 consecutive months;
- • normal-high resting blood pressure (120 ≤ Systolic ≤ 139 mmHg and 80 ≤ Diastolic ≤ 89 mmHg) or stage 1 hypertension (140 ≤ Systolic ≤ 159 mmHg or 90 \< Diastolic ≤ 99 mmHg);
- • physically inactive (\< 150 minutes of structured aerobic physical activity per week);
- • and not engaging in regular resistance exercise (≥ 2 sessions per week) for more than 3 months during the year.
- Exclusion Criteria:
- • orthopedic limitations or other contraindications to resistance exercise;
- • scheduled surgery during the study;
- • unstable hypertension (≥ 160/100 mmHg);
- • diagnosis of type 2 diabetes;
- • cardiovascular event in the past 6 months or sequelae preventing exercise;
- • and initiation of hormonal replacement therapy (\< 4 months) known to affect blood pressure.
About Université De Sherbrooke
The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sherbrooke, Quebec, Canada
Patients applied
Trial Officials
Eléonor Riesco, Ph.D.
Principal Investigator
Université de Sherbrooke
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported